{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:10:32Z","timestamp":1789567832505,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-04993-8","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T03:35:48Z","timestamp":1724124948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Farah D. R.","family":"Al-Baiaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareena","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizah","family":"Mohd Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farin","family":"Masra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayang Anita","family":"Abdul Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Nurulhuda","family":"Wan Md Zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Yee Hing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azrina Syarizad","family":"Kuthubul Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhazlina","family":"Abdul Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairul Najmi","family":"Muhammad Nawawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zalina","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Affendi","family":"Raja Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norfilza Mohd","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"4993_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.992264","volume":"13","author":"K Marcinkiewicz","year":"2022","unstructured":"Marcinkiewicz K, Horodnicka-J\u00f3zwa A, Jackowski T, Str\u0105czek K, Biczysko-Mokosa A, Walczak M, Petriczko E. Nonalcoholic fatty liver disease in children with obesity\u2013observations from one clinical centre in the Western Pomerania region. Front Endocrinol. 2022;13: 992264.","journal-title":"Front Endocrinol"},{"issue":"3","key":"4993_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cld.1008","volume":"17","author":"C Phen","year":"2021","unstructured":"Phen C, Ramirez CM. Hepatic steatosis in the pediatric population: an overview of pathophysiology, genetics, and diagnostic workup. Clin Liver Dis. 2021;17(3):191.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4993_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-021-02595-2","volume":"21","author":"L Peng","year":"2021","unstructured":"Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. BMC Pediatr. 2021;21(1):1\u20138.","journal-title":"BMC Pediatr"},{"issue":"47","key":"4993_CR4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i47.8277","volume":"23","author":"G Ranucci","year":"2017","unstructured":"Ranucci G, Spagnuolo MI, Iorio R. Obese children with fatty liver: between reality and disease mongering. World J Gastroenterol. 2017;23(47): 8277.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4993_CR5","first-page":"208","volume":"28","author":"J Li","year":"2020","unstructured":"Li J, Ren W. Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children. Zhonghua gan Zang Bing za zhi= Zhonghua Ganzangbing Zazhi= Chinese. J Hepatol. 2020;28(3):208\u201312.","journal-title":"J Hepatol"},{"key":"4993_CR6","doi-asserted-by":"crossref","unstructured":"Mann JP, Valenti L, Scorletti E, Byrne CD, Nobili V: Nonalcoholic fatty liver disease in children. In: Seminars in liver disease: 2018: Thieme Medical Publishers; 2018: 001\u2013013.","DOI":"10.1055\/s-0038-1627456"},{"key":"4993_CR7","volume-title":"The State of the World's Children 2019. Children, Food and Nutrition: Growing well in a changing world","author":"UNICEF","year":"2019","unstructured":"UNICEF. The State of the World\u2019s Children 2019. Children, Food and Nutrition: Growing well in a changing world. New York: UNICEF; 2019."},{"issue":"2","key":"4993_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1515\/jpem-2019-0403","volume":"33","author":"RZ Mohamed","year":"2020","unstructured":"Mohamed RZ, Jalaludin MY, Zaini AA. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatr Endocrinol Metab. 2020;33(2):247\u201353.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"4993_CR9","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Taub R, Neff GW, Lucas KJ, Labriola D, Moussa SE, Alkhouri N, Bashir MR. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023;29(11):2919\u201328.","journal-title":"Nat Med"},{"issue":"7","key":"4993_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1053\/j.gastro.2020.01.048","volume":"158","author":"D Goldner","year":"2020","unstructured":"Goldner D, Lavine JE. Nonalcoholic fatty liver disease in children: unique considerations and challenges. Gastroenterology. 2020;158(7):1967\u201383 e1961.","journal-title":"Gastroenterology"},{"key":"4993_CR11","doi-asserted-by":"publisher","first-page":"667247","DOI":"10.3389\/fped.2021.667247","volume":"9","author":"FD Al-Baiaty","year":"2021","unstructured":"Al-Baiaty FD, Ismail A, Abdul Latiff Z, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Possible hepatoprotective effect of tocotrienol-rich fraction vitamin E in non-alcoholic fatty liver disease in obese children and adolescents. Front Pediatr. 2021;9:667247.","journal-title":"Front Pediatr"},{"issue":"0020","key":"4993_CR12","first-page":"30680","volume":"S0016\u20135085","author":"V Ratziu","year":"2020","unstructured":"Ratziu V, Friedman SL. Why do so many NASH trials fail? Gastroenterology. 2020;S0016\u20135085(0020):30680.","journal-title":"Gastroenterology"},{"issue":"2","key":"4993_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021703","volume":"24","author":"R Nevola","year":"2023","unstructured":"Nevola R, Epifani R, Imbriani S, Tortorella G, Aprea C, Galiero R, Rinaldi L, Marfella R, Sasso FC. GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives. Int J Mol Sci. 2023;24(2): 1703.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4993_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6040086","volume":"6","author":"BJ Perumpail","year":"2018","unstructured":"Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The role of vitamin E in the treatment of NAFLD. Diseases. 2018;6(4): 86.","journal-title":"Diseases"},{"issue":"11","key":"4993_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113531","volume":"12","author":"G Alberti","year":"2020","unstructured":"Alberti G, Gana JC, Santos JL. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. Nutrients. 2020;12(11): 3531.","journal-title":"Nutrients"},{"issue":"1","key":"4993_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"key":"4993_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102494","volume":"52","author":"MA Pervez","year":"2020","unstructured":"Pervez MA, Khan DA, Slehria AUR, Ijaz A. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Complement Ther Med. 2020;52: 102494.","journal-title":"Complement Ther Med"},{"issue":"5","key":"4993_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, Kashyap S, Mechanick JI, Mouzaki M, Nadolsky K. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28(5):528\u201362.","journal-title":"Endocr Pract"},{"issue":"3","key":"4993_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cld.1027","volume":"17","author":"LY Elizabeth","year":"2021","unstructured":"Elizabeth LY, Schwimmer JB. Epidemiology of pediatric nonalcoholic fatty liver disease. Clinical Liver Disease. 2021;17(3):196\u20139.","journal-title":"Clinical Liver Disease"},{"issue":"76\u201383","key":"4993_CR20","volume":"198","author":"KE Harlow","year":"2018","unstructured":"Harlow KE, Africa JA, Wells A, Belt PH, Behling CA, Jain AK, Molleston JP, Newton KP, Rosenthal P, Vos MB. Clinically actionable hypercholesterolemia and hypertriglyceridemia in children with nonalcoholic fatty liver disease. J Pediatr. 2018;198(76\u201383): e72.","journal-title":"J Pediatr"},{"key":"4993_CR21","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202020190449","volume":"92","author":"A Gama","year":"2020","unstructured":"Gama A, Rosado-Marques V, Machado-Rodrigues AM, Nogueira H, Mourao I, Padez C. Prevalence of overweight and obesity in 3-to-10-year-old children: assessment of different cut-off criteria WHO-IOTF. An Acad Bras Ci\u00eanc. 2020;92: e20190449.","journal-title":"An Acad Bras Ci\u00eanc"},{"issue":"4","key":"4993_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/156482651203300404","volume":"33","author":"H Ene-Obong","year":"2012","unstructured":"Ene-Obong H, Ibeanu V, Onuoha N, Ejekwu A. Prevalence of overweight, obesity, and thinness among urban school-aged children and adolescents in southern Nigeria. Food Nutr Bull. 2012;33(4):242\u201350.","journal-title":"Food Nutr Bull"},{"key":"4993_CR23","unstructured":"Ismail IS, Bebakar W, Kamaruddin N, Abdullah N, Zin F, Taib S. Clinical practice guidelines on management of obesity. Putrajaya: Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Association for the Study of Obesity, Malaysian Endocrine and Metabolic Society; 2004."},{"key":"4993_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01290","volume":"9","author":"PC Baumgartner","year":"2018","unstructured":"Baumgartner PC, Haynes RB, Hersberger KE, Arnet I. A systematic review of medication adherence thresholds dependent of clinical outcomes. Front Pharmacol. 2018;9: 1290.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4993_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13105","volume":"19","author":"JL Castro-Mejia","year":"2020","unstructured":"Castro-Mejia JL, Khakimov B, Krych L, Bulow J, Bechshoft RL, Hojfeldt G, Mertz KH, Garne ES, Schacht SR, Ahmad HF, et al. Physical fitness in community-dwelling older adults is linked to dietary intake, gut microbiota, and metabolomic signatures. Aging Cell. 2020;19(3): e13105.","journal-title":"Aging Cell"},{"issue":"2","key":"4993_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","volume":"71","author":"J Boursier","year":"2019","unstructured":"Boursier J, Guillaume M, Leroy V, Irl\u00e8s M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudi\u00e8re C, Barthelon J. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J Hepatol. 2019;71(2):389\u201396.","journal-title":"J Hepatol"},{"issue":"11","key":"4993_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112415","volume":"10","author":"Vali Y, Lee J, Boursier J, Spijker R, Verheij J, Brosnan MJ, Anstee QM, Bossuyt PM, Zafarmand MH, Team LSR","year":"2021","unstructured":"Vali Y, Lee J, Boursier J, Spijker R, Verheij J, Brosnan MJ, Anstee QM, Bossuyt PM, Zafarmand MH, Team LSR. FibroTest for evaluating fibrosis in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. J Clin Med. 2021;10(11): 2415.","journal-title":"J Clin Med"},{"issue":"7","key":"4993_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jgh.12557","volume":"29","author":"WK Chan","year":"2014","unstructured":"Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2014;29(7):1470\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4993_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184\u201391.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4993_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/mutage\/gex040","volume":"33","author":"EE Bankoglu","year":"2018","unstructured":"Bankoglu EE, Seyfried F, Arnold C, Soliman A, Jurowich C, Germer CT, Otto C, Stopper H. Reduction of DNA damage in peripheral lymphocytes of obese patients after bariatric surgery-mediated weight loss. Mutagenesis. 2018;33(1):61\u20137.","journal-title":"Mutagenesis"},{"issue":"2","key":"4993_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/mutage\/geaa001","volume":"35","author":"ML Magenis","year":"2020","unstructured":"Magenis ML, Damiani AP, de Marcos PS, de Pieri E, de Souza E, Vilela TC, de Andrade VM. Fructose consumption during pregnancy and lactation causes DNA damage and biochemical changes in female mice. Mutagenesis. 2020;35(2):179\u201387.","journal-title":"Mutagenesis"},{"issue":"5","key":"4993_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1017\/S0007114517000204","volume":"117","author":"F Mofidi","year":"2017","unstructured":"Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. Br J Nutr. 2017;117(5):662\u20138.","journal-title":"Br J Nutr"},{"issue":"3","key":"4993_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/molecules21030344","volume":"21","author":"L Zhao","year":"2016","unstructured":"Zhao L, Fang X, Marshall MR, Chung S. Regulation of obesity and metabolic complications by gamma and delta tocotrienols. Molecules. 2016;21(3):344.","journal-title":"Molecules"},{"issue":"6","key":"4993_CR34","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/gutjnl-2014-307142","volume":"64","author":"FF Anhe","year":"2015","unstructured":"Anhe FF, Roy D, Pilon G, Dudonne S, Matamoros S, Varin TV, Garofalo C, Moine Q, Desjardins Y, Levy E, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872\u201383.","journal-title":"Gut"},{"issue":"12","key":"4993_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122900","volume":"11","author":"G Napolitano","year":"2019","unstructured":"Napolitano G, Fasciolo G, Di Meo S, Venditti P. Vitamin E supplementation and mitochondria in experimental and functional hyperthyroidism: a mini-review. Nutrients. 2019;11(12): 2900.","journal-title":"Nutrients"},{"key":"4993_CR36","doi-asserted-by":"crossref","unstructured":"J Majima H, P Indo H, Suenaga S, Matsui H, Yen HC, Ozawa T. Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases. Curr Pharm Des. 2011;17(21):2190-2195.","DOI":"10.2174\/138161211796957490"},{"key":"4993_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnesp.2017.07.004","volume":"21","author":"JA Goon","year":"2017","unstructured":"Goon JA, Azman NHEN, Ghani SMA, Hamid Z, Ngah WZW. Comparing palm oil tocotrienol rich fraction with \u03b1-tocopherol supplementation on oxidative stress in healthy older adults. Clin Nutr ESPEN. 2017;21:1\u201312.","journal-title":"Clin Nutr ESPEN"},{"issue":"7346","key":"4993_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174\u201380.","journal-title":"Nature"},{"issue":"367","key":"4993_CR39","first-page":"2","volume":"6","author":"A Qureshi","year":"2015","unstructured":"Qureshi A, Khan D, Mahjabeen W, Trias A, Silswal N, Qureshi N. Impact of \u03b4-tocotrienol on inflammatory biomarkers and oxidative stress in hypercholesterolemic subjects. J Clin Exp Cardiolog. 2015;6(367):2.","journal-title":"J Clin Exp Cardiolog"},{"issue":"1","key":"4993_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-020-00570-y","volume":"12","author":"AF Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, J\u00fanior WSS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12(1):1\u201320.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4993_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22\u201341.","journal-title":"Cell Metab"},{"issue":"5","key":"4993_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"4993_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cld.918","volume":"15","author":"EF Miller","year":"2020","unstructured":"Miller EF. Nutrition management strategies for nonalcoholic fatty liver disease: treatment and prevention. Clin Liver Dis. 2020;15(4):144.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4993_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antiox7010012","volume":"7","author":"HE Hadi","year":"2018","unstructured":"Hadi HE, Vettor R, Rossato M. Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth? Antioxidants. 2018;7(1):12.","journal-title":"Antioxidants"},{"issue":"3","key":"4993_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.08.008","volume":"45","author":"M Lin","year":"2021","unstructured":"Lin M, Zeng H, Deng G, Lei J, Li J. Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis. Clin Res Hepatol Gastroenterol. 2021;45(3): 101530.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"4993_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4331\/wjbc.v7.i1.14","volume":"7","author":"L Schm\u00f6lz","year":"2016","unstructured":"Schm\u00f6lz L, Birringer M, Lorkowski S, Wallert M. Complexity of vitamin E metabolism. World J Biol Chem. 2016;7(1):14.","journal-title":"World J Biol Chem"},{"issue":"7","key":"4993_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071284","volume":"11","author":"M Civelek","year":"2022","unstructured":"Civelek M, Podszun MC. Genetic factors associated with response to vitamin E treatment in NAFLD. Antioxidants. 2022;11(7): 1284.","journal-title":"Antioxidants"},{"issue":"16","key":"4993_CR48","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659\u201368.","journal-title":"JAMA"},{"issue":"1","key":"4993_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-12-166","volume":"12","author":"E Magosso","year":"2013","unstructured":"Magosso E, Ansari MA, Gopalan Y, Shuaib IL, Wong J-W, Khan NAK, Abu Bakar MR, Ng B-H, Yuen K-H. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutr J. 2013;12(1):1\u20138.","journal-title":"Nutr J"},{"issue":"2","key":"4993_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3945\/jn.113.185561","volume":"144","author":"SB Murer","year":"2014","unstructured":"Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, Taylor AW, Traber MG, Zimmermann MB. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J Nutr. 2014;144(2):193\u2013201.","journal-title":"J Nutr"},{"issue":"2","key":"4993_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/ars.2018.7704","volume":"31","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Mosca A, Crudele A, Zaffina S, Denaro M, Smeriglio A, Trombetta D. The antioxidant effects of hydroxytyrosol and vitamin E on pediatric nonalcoholic fatty liver disease, in a clinical trial: a new treatment? Antioxid Redox Signal. 2019;31(2):127\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"4993_CR52","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16(9):517\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4993_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-017-0617-6","volume":"17","author":"G Ferraioli","year":"2017","unstructured":"Ferraioli G, Calcaterra V, Lissandrin R, Guazzotti M, Maiocchi L, Tinelli C, De Silvestri A, Regalbuto C, Pelizzo G, Larizza D. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter. BMC Gastroenterol. 2017;17(1):1\u20139.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"4993_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5152\/tjg.2018.17297","volume":"29","author":"MA Pervez","year":"2018","unstructured":"Pervez MA, Khan DA, Ijaz A, Khan S. Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. Turk J Gastroenterol. 2018;29(2):170.","journal-title":"Turk J Gastroenterol"},{"issue":"1129","key":"4993_CR55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/postgradmedj-2018-136364","volume":"95","author":"I Amanullah","year":"2019","unstructured":"Amanullah I, Khan YH, Anwar I, Gulzar A, Mallhi TH, Raja AA. Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials. Postgrad Med J. 2019;95(1129):601\u201311.","journal-title":"Postgrad Med J"},{"key":"4993_CR56","doi-asserted-by":"publisher","first-page":"175628482097491","DOI":"10.1177\/1756284820974917","volume":"13","author":"M Abdel-Maboud","year":"2020","unstructured":"Abdel-Maboud M, Menshawy A, Menshawy E, Emara A, Alshandidy M, Eid M. The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Ther Adv Gastroenterol. 2020;13:1756284820974917.","journal-title":"Ther Adv Gastroenterol"},{"issue":"17","key":"4993_CR57","doi-asserted-by":"publisher","first-page":"e6770","DOI":"10.1097\/MD.0000000000006770","volume":"96","author":"JL Martin-Rodriguez","year":"2017","unstructured":"Martin-Rodriguez JL, Gonzalez-Cantero J, Gonzalez-Cantero A, Arrebola JP, Gonzalez-Calvin JL. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. Medicine. 2017;96(17):e6770.","journal-title":"Medicine"},{"issue":"8","key":"4993_CR58","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc19-0167","volume":"42","author":"F Bril","year":"2019","unstructured":"Bril F, Biernacki DM, Kalavalapalli S, Lomonaco R, Subbarayan SK, Lai J, Tio F, Suman A, Orsak BK, Hecht J. Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2019;42(8):1481\u20138.","journal-title":"Diabetes Care"},{"issue":"14","key":"4993_CR59","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2011.1437","volume":"306","author":"EA Klein","year":"2011","unstructured":"Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al. Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549\u201356.","journal-title":"JAMA"},{"issue":"4","key":"4993_CR60","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cgh.2018.06.011","volume":"17","author":"MAT Han","year":"2019","unstructured":"Han MAT, Altayar O, Hamdeh S, Takyar V, Rotman Y, Etzion O, Lefebvre E, Safadi R, Ratziu V, Prokop LJ. Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(4):616\u201329 e626.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4993_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104209","volume":"74","author":"SK Wong","year":"2020","unstructured":"Wong SK, Chin K-Y, Ahmad F, Ima-Nirwana S. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease. J Functional Foods. 2020;74: 104209.","journal-title":"J Functional Foods"},{"issue":"14","key":"4993_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411307","volume":"24","author":"S Zi\u00f3\u0142kowska","year":"2023","unstructured":"Zi\u00f3\u0142kowska S, Kosmalski M, Ko\u0142odziej \u0141, Jab\u0142kowska A, Szemraj JZ, Pietras T, Jab\u0142kowski M, Czarny PL. Single-nucleotide polymorphisms in base-excision repair-related genes involved in the risk of an occurrence of non-alcoholic fatty liver disease. Int J Mol Sci. 2023;24(14): 11307.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4993_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091383","volume":"10","author":"M Trujillo","year":"2021","unstructured":"Trujillo M, Kharbanda A, Corley C, Simmons P, Allen AR. Tocotrienols as an anti-breast cancer agent. Antioxidants. 2021;10(9): 1383.","journal-title":"Antioxidants"},{"issue":"3","key":"4993_CR64","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ijo.2014.124","volume":"39","author":"L Zhao","year":"2015","unstructured":"Zhao L, Kang I, Fang X, Wang W, Lee MA, Hollins RR, Marshall MR, Chung S. Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment. Int J Obes (Lond). 2015;39(3):438\u201346.","journal-title":"Int J Obes (Lond)"},{"key":"4993_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2022.102866","volume":"70","author":"MA Pervez","year":"2022","unstructured":"Pervez MA, Khan DA, Mirza SA, Slehria AUR, Nisar U, Aamir M. Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized double-blind active-controlled trial. Complement Ther Med. 2022;70: 102866.","journal-title":"Complement Ther Med"},{"issue":"4","key":"4993_CR66","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3892\/mmr.2012.770","volume":"5","author":"T Matsunaga","year":"2012","unstructured":"Matsunaga T, Shoji A, Gu N, Joo E, Li S, Adachi T, Yamazaki H, Yasuda K, Kondoh T, Tsuda K. \u03b3-Tocotrienol attenuates TNF-\u03b1-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol Med Rep. 2012;5(4):905\u20139.","journal-title":"Mol Med Rep"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04993-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:04:05Z","timestamp":1724177045000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04993-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4993"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04993-8","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and was approved by the Universiti Kebangsaan Malaysia ethics committee [UKM PPI\/111\/8\/JEP-2018621]. Informed consent to participate in this study was obtained from all participants. For participants who were younger than the age of 16, consent was obtained from their parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors hereby declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}